Doctor Anderson Woite-Silva
InCarda Therapeutics, Newark (United States of America)
Membership:
ESC Professional Member
Follow
Contributor content
Journal
Flecainide acetate inhalation solution for cardioversion of recent-onset, symptomatic atrial fibrillation: results of the phase 3 RESTORE-1 trial
28 October 2024
